Alien spaceship – UFOs in solar space on NASA satellite images in the review of the October 26, 2014 – Video


Alien spaceship - UFOs in solar space on NASA satellite images in the review of the October 26, 2014
NASA practically stopped giving public information from satellites, watching over the sun, but some things NASA officials passed and we can see that the presence of UFOs in solar space continues!

By: myunhauzen74

Read the rest here:

Alien spaceship - UFOs in solar space on NASA satellite images in the review of the October 26, 2014 - Video

Dear NASA, could giant sharks live on the sun?

A new set of images taken on board NASA's Solar and Heliospheric Observatory (SOHO) last week show an angular fin-shaped object, potentially the size of the Earth, in front of the sun.

The images, taken as NASA monitor's recent sunspot activity, have UFO enthusiasts talking about a technologically advanced race of beings siphoning energy from the sun, while those more down-to-earth say its just a camera glitch.

No matter what it turns out to be, this kind of science news is an inexhaustible source of parenting power when it comes to harnessing the energy of kids to research, imagine, and get creative with new and unusual scientific information.

One of the better, more scientific, data-based videos on the unidentified object I found with my 10-year-old son before he left for school this morning was posted by the website Suspicious Observers.

The video is part of The Mobile Observatory Project, started by Suspicious Observers, which was created by Ohio Lawyer and space enthusiast Ben Davidson.

However scientifically sound, kids may prefer the more colorful, sci-fi television show-inspired version of the news, complete with Star Trek style theme music posted to YouTube by HighTechAddict.

In the latter video, we see something resembling a Portugese Man-o-war jellyfish with tendrils that extend down to the sun as it allegedly siphons solar energy and then skedaddles back into space.

After watching both videos and examining photos from the NASA website, my son Quin said, It could just be a sun shark.

Rather than dismiss this pronouncement, I asked him what he based it on.

I was kidding mom. I was mocking the idea that aliens are sucking energy out of the sun, Quin said. But it would be really cool to imagine the surface of the sun is like the ocean and these sharks are born there, swimming around like leviathans.

Originally posted here:

Dear NASA, could giant sharks live on the sun?

NASA Glenn Director of Aeronautics to Speak at IEEE Cleveland Section

NASAs Glenn Research Center Aeronautics Director Therese M. Griebel will address the Institute of Electrical and Electronics Engineers (IEEE) Cleveland Section from 6 to 8 p.m., on Tuesday, Oct. 28. The IEEE is the worlds largest professional association for the advancement of technology. The event takes place at the Oak Barrel, located at 5975 Canal Road in Valley View.

Griebel will address the historical accomplishments of Glenn and Plum Brook Station in Sandusky, Ohio; and the centers support of NASA and national priorities in aeronautics, space science, space technology development and human exploration. Appointed director of Aeronautics in 2014, Griebel is responsible for overseeing Glenns aeronautics program.

A native of Northeast Ohio, Griebel began her NASA career at Glenn in 1991. She managed the technology program for advanced radioisotope power conversion technologies in 2002 at NASA Headquarters in Washington, D.C., and the technology portfolio at the Jet Propulsion Laboratory in Pasadena, California for the Prometheus Project from 2003 to 2005.

Griebel also served as the deputy chief for Glenns Orion Project Office in 2006; a capture manager for defense satellite systems at Raytheon Missile Systems in Tucson Arizona in 2007; chief of Manufacturing Division at Glenn from 2007 to 2010 and chief of Avionics and Electrical Systems Division from 2010 to 2014.

Media interested in attending must RSVP tomaximilian.c.scardelletti@nasa.gov.

To learn more about NASA Glenn, visit:

http://www.nasa.gov/centers/glenn

For more information about the event, visit:

http://www.clevelandieee.org/

See the original post here:

NASA Glenn Director of Aeronautics to Speak at IEEE Cleveland Section

NASA International Space Station Commander to speak at BSU

NASA astronaut and Boise State University Professor of the Practice Steve Swanson will share stories about his time aboard the International Space Station at 6:30 p.m. Wednesday, Nov. 12, in the Student Union Simplot Ballroom on the BSU Campus.

The event is free and open to the public. Hourly parking is available in the Lincoln Avenue Garage.

Swanson spent six months in orbit on the ISS, from March to September 2014; in May he took over as commander of Expedition 40.

During a live downlink from space sponsored by the Space Broncos student group, Swanson spoke with Boise State students and the community -- and demonstrated some of the unusual aspects of living in microgravity. The downlink was part of Boise States Space Symposium, which included presentations by students and faculty engaged in NASA-related research and education programs.

Swanson will also present Boise State University with a ball cap he wore during that downlink from space at a special on-field recognition during the Nov. 15 football game against San Diego State in Albertsons Stadium.

While in Boise, Swanson will visit with engineering students and tour several research labs on campus.

Steve Swansons visit is a great boost for our students and faculty and it reminds us that NASA is an integral part of our community, said Barbara Morgan, former NASA astronaut and current distinguished educator in residence at Boise State. We are pleased to have several strong ties to NASA, including NASA-funded research programs, participation in the Microgravity University and Zero Robotics programs, student internships, the NASA Pre-Service Teacher Institute, the McNair Scholars Program, Idaho Science and Aerospace Scholars and our own Space Broncos Team Swanson student organization.

Swanson, who has a Ph.D. in computer science, became an astronaut in 1998. His flight experience includes two space shuttle missions and one long-duration mission on the International Space Station. On the 2007 Atlantis shuttle mission, Swanson helped deliver, install and repair equipment and performed two spacewalks on the space station. On 2009s Discovery shuttle mission to the space station, Swanson again delivered and installed equipment and performed two spacewalks. As commander of the International Space Stations Expedition 40, he led the team of astronauts and cosmonauts and conducted science and technology experiments.

Swanson and his family live in Houston, Texas. His parents live in Eagle, Idaho.

Steve Swanson is one of five Boise State University Professors of the Practice.

Read this article:

NASA International Space Station Commander to speak at BSU

NASA Media Accreditation Opens for Launch of Next SpaceX Station Resupply Mission

Media accreditation is open for the launch of NASA's next commercial cargo resupply flight to the International Space Station.

SpaceX is currently targeting no earlier than Dec. 9 for liftoff of its Dragon spacecraft atop a Falcon 9 rocket from Cape Canaveral Air Force Station (CCAFS) in Florida. This will be the company's sixth visit to the space station and fifth commercial resupply mission, delivering several tons of supplies, including new science experiments and technology research.

Prelaunch and launch activities for media will take place at CCAFS and nearby at NASA's Kennedy Space Center. International media without U.S. citizenship must apply for credentials to cover activities by Nov. 2 to gain access to CCAFS for the launch. Accreditation is open until 4:30 p.m. Nov. 17 for international media without U.S. citizenship who do not need access to CCAFS. The deadline for U.S. media to apply for credentials is 4:30 p.m. Nov. 21.

All media accreditation requests must be submitted online at:

https://media.ksc.nasa.gov

International journalists must submit a scanned copy of their "I" visa and passport. Green card holders must submit a scanned copy of their card. Questions about accreditation and all scanned documents should be directed to Jennifer Horner atjennifer.p.horner@nasa.gov, 321-867-6598 or 321-867-2468.

All media representatives must present two forms of legal, government identification to access Kennedy. One form must be a photo ID, such as a passport or driver's license.

For more information about the SpaceX resupply mission, visit:

http://www.nasa.gov/spacex

Link:

NASA Media Accreditation Opens for Launch of Next SpaceX Station Resupply Mission

NASA Administrator to Visit Marshall Space Flight Center; Talks Space Station Oct. 28

NASA Administrator Charles Bolden will get a behind-the-scenes look at the science command post for the International Space Station when he visits NASA's Payload Operations Integration Center at the Marshall Space Flight Center in Huntsville, Alabama, Oct. 28.

Journalists are invited to participate in the tour and media availability with Bolden at 11 a.m. CDT. Bolden will call space station Expedition 41 Flight Engineer Barry E. "Butch" Wilmore, who currently is living and working on the orbiting laboratory, at 11:30 a.m. from the control center. The phone call will be carried live on NASA Television.

The Marshall Payload Operations Integration Center allows researchers around the world to perform cutting-edge science in space by providing communications between investigators and the astronauts in orbit. Bolden also will chat with the expert payload operations team, which has helped conduct more than 1,500 science investigations and student experiments from 82 countries.

Media interested in attending must contact Jennifer Stanfield in Marshall's Public and Employee Communications Office at 256-544-0034 no later than 3 p.m. Monday, Oct. 27. Media must report to the Redstone Arsenal Joint Visitor Control Center at Gate 9, Interstate 565 interchange at Rideout Road/Research Park Boulevard by 10 a.m. on Oct. 28. Vehicles are subject to a security search at the gate. Media will need two photo identifications and proof of car insurance.

For NASA TV schedule and video streaming information, visit:

NASA TV Live

For more information about the International Space Station, visit:

http://www.nasa.gov/station

For Wilmore's biography, visit:

Read the original:

NASA Administrator to Visit Marshall Space Flight Center; Talks Space Station Oct. 28

NASA seeks ultra-lightweight materials to help enable journey to Mars

13 hours ago by David E. Steitz

NASA is seeking proposals to develop and manufacture ultra-lightweight materials for aerospace vehicles and structures of the future. Proposals will demonstrate lower-mass alternatives to honeycomb or foam cores currently used in composite sandwich structures.

Composite sandwich structures are a special type of material made by attaching two thin skins to a lightweight core. This type of composite is used extensively within the aerospace industry and in other applications where reducing weight while maintaining structural strength is important. A common use for these sorts of composites is the shrouds for launch vehicles and other key technology components that will enable our journey to Mars.

The goal of this Game Changing Development Program effort is to develop and demonstrate scalable and cost-effective manufacturing approaches to produce ultra-lightweight core materials both as flat panels and curved structures. The final products will have half or less the area density of conventional honeycomb cores, with equal or better mechanical properties.

Over the next year, NASA's Space Technology Mission Directorate (STMD) will continue to seek industry and university partnerships to assure the agency has the capabilities it needs, while helping America maintain its leadership in the technology-driven global economy. These investments will focus on in-space propulsion and advanced high-power solar arrays; robotics and avionics for outer planetary exploration, especially high-reliability and low-mass, deep ice penetration systems; advanced materials, including large composite structures; and space observatory systems, with a focus on advanced optical coating materials.

"Technology drives exploration and ultra-lightweight materials will play a key role in our future missions," said Michael Gazarik, associate administrator for Space Technology at NASA Headquarters in Washington. "This call for proposals continues a cadence of solicitations that touch on a specific set of thrust areas needed to push human and robotic exploration farther in the solar system."

The reduced mass will lead to an increase in NASA's mission capability while decreasing mission costs and also may provide spinoffs that benefit diverse sectors of the economy and increase the nation's competitiveness.

Proposals will be accepted from U.S. organizations, including NASA centers and other government agencies, federally funded research and development centers, educational institutions, industry and nonprofit organizations. NASA expects to make two awards of up to $550,000 each for this first development phase.

The solicitation, entitled SpaceTech-REDDI-2015 NNH15ZOA001N-15GCD-C1 Ultra-lightweight Core Materials for Efficient Load-Bearing Composite Sandwich Structures Appendix, is available through the NASA Solicitation and Proposal Integrated Review and Evaluation System website by going to "Solicitations" and then "Open Solicitations" at: nspires.nasaprs.com/

Explore further: NASA selects proposals for advanced energy storage systems

Link:

NASA seeks ultra-lightweight materials to help enable journey to Mars

Oxford University's big data and Internet of Things project to 'create the NASA of biomedicine'

Care for cancer patients within the NHS will be radically improved through the combined power of such technologies as big data, informatics and Internet of Things-connected devices to sequence the genomes of individual patients.

That's what a collaboration between the University of Oxford and the US-based Chan Soon-Shiong Institute of Molecular Medicine is hoping to achieve.

The plan has the full backing of the government, with Minister for Life Sciences George Freeman MP, who was at the event, likening its ambition to that of NASA when it was aiming for the Moon.

"This is a project to sequence the full genome of 100,000 patient volunteers in the NHS and combine it with the hospital clinical data," he said.

"We're creating the world's first at-scale dataset [of the genome], the NASA of biomedicine, which will help to shape the precision medicine landscape in the 21st century. Pulling together the two transformational technologies of genomics and informatics will allow us to practise in our health system a much more targeted, precise model of medicine for the benefit of patients," Freeman added.

When Computing asked about the technology behind the genome project, Dr Patrick Soon-Shiong, founder and chairman of the Chan Soon-Shiong Institute for Molecular Medicine, gave some insights into the computing power that will be harnessed to diagnose and treat cancer.

He explained that examining the genome of just one patient represents half a terabyte of data. Therefore, to collect and analyse data from many thousands of patients will require the resources of a supercomputer.

"If you look at the US, there's 13 million cancer survivors, which translates to 4,000 or 5,000 a day. That's equivalent to 50 to 60 times the download of information from Facebook every day," Dr Soon-Shiong said.

This is why a phenomenal amount of computing power is required to extract data from the "tiny matter" of the genome.

"The first thing that was needed was an infrastructure of data transfer which had never actually been considered on this planet before. So we had to actually create an infrastructure which could move all that data; this is now active," Dr Soon-Shiong told Computing.

Read the original here:

Oxford University's big data and Internet of Things project to 'create the NASA of biomedicine'

Thyroid Gland Problems Hormones – Alternatives to Surgery Functional Medicine – Video


Thyroid Gland Problems Hormones - Alternatives to Surgery Functional Medicine
Exclusive Content @ http://www.patreon.com/psychetruth Thyroid Gland Problems Hormones - Alternatives to Surgery Functional Medicine Psychetruth News Corresp...

By: PsycheTruth

Read more from the original source:

Thyroid Gland Problems Hormones - Alternatives to Surgery Functional Medicine - Video

Is your teen abusing cough medicine?

Christy Crandell wants you to know something.

Her son served prison time for armed robbery something he did while under the influence of over-the-counter cough medicine.

It was something I completely missed when my kids were growing up, she said. We had no idea about cough medicine abuse. She doesnt want you to miss the same thing.

Think about it. Cough medicine. So easy to get, right there in your own medicine cabinet. Parents sometimes dont understand how serious it can get, she said. Its so accessible and if you dont know about it, youre not doing anything to safeguard.

Unfortunately, Crandell isnt the only mother who discovered these amazing facts about cough medicine. And so she is helping get the word out, partly through a campaign called #tomyteen during this, National Medicine Abuse Awareness Month.

The hashtag crusade is aimed to show our teens that we think they are pretty awesome. It sounds obvious, but its important to remember that teens who are validated and appreciated by their parents are much less likely to fall to bad peer pressure.

Parents are looking for positive ways to interact with teens, rather than lecture or punish them, said Scott Melville, the CEO of the Consumer Healthcare Products Association. He said CHPAs members started hearing that cough medicine was being abused, particularly by teens, starting about 10 years ago. One in 25 teens abuses cough medicine, he said. Thats one kid in every classroom.

The big issue here, said Deborah Gilboa, a family physician and mother of four boys, is that as parents, were never going to be standing there next to them when they are facing a decision that has serious consequences. She offers three things you can do to help kids faced with peer pressure or the desire to just give something like this a try:

Dont leave any subject off limits. If you dont tell your kids what your views are, they will only listen to popular culture or peers. They should get to hear what we think. You want them to know that you know what they are facing.

You should be trustworthy. Live the values you talk about. If you think texting and driving is a dangerous thing to do, you have to actually not text and drive yourself. If you want your child to call you when they are in a bad spot socially, you have to actually make yourself available so they know they have a safe place to land. Tell them, Gilboa said, I know youve told me that there wont be drinking at this party. But if there is and you find yourself in a bad spot, call me and you wont get in trouble. And then mean it when they call.

See the original post here:

Is your teen abusing cough medicine?

Drug for Rare Blood Disorder Developed at Penn Receives Orphan Drug Status from the FDA

Contact Information

Available for logged-in reporters only

Newswise PHILADELPHIA A Penn Medicine-developed drug has received orphan status from the Food and Drug Administration (FDA) this month for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare, life-threatening disease that causes anemia due to destruction of red blood cells and thrombosis. This designation comes less than two months after the European Medicines Agency (EMA) approved the drug for the same status.

Orphan designation for the drug, called AMY-101, will allow Amyndas, the company currently developing the compound, to proceed with expedited clinical development. Amyndas is planning to move AMY-101 into the clinic for first-in-human trials in 2015. AMY-101 is a new way to fight PNH, which is currently only treatable with the most expensive drug available for sale in the United States. The new strategy is based on inhibiting C3, a central component of the oldest part of the human immune system called complement -- and could turn out to be less costly and more effective for the majority of patients with this rare blood disorder.

If a drug is approved by the FDA, this special orphan status allows for a seven-year period of market exclusivity from product launch in the United States, and enables an orphan drugs maker to apply for research funding, tax credits for certain research expenses, and assistance for clinical research study design. This status also provides a waiver from the FDAs Prescription Drug User Fee, which authorizes the FDA to collect fees from drug sponsors to expand their staff so that new drugs can be reviewed more quickly.

John Lambris, PhD, the Dr. Ralph and Sallie Weaver Professor of Research Medicine in the Department of Pathology and Laboratory Medicine in the Perelman School of Medicine, developed AMY-101 at Penn, and in 2013 the university licensed it to Amyndas, which is now further developing the compound for application in the clinic.

Receiving the orphan drug designation from both the FDA and the EMA is an important achievement and a key milestone in the development pathway of AMY-101 and we are optimistic regarding the long-term potential of this potent complement inhibitor, said Lambris. AMY-101 could represent a significant therapeutic advantage over treatments currently available for PNH.

PNH affects between 1 and 5 per million people and is caused by a defective expression of regulatory proteins on the surface of blood cells, leaving them vulnerable to complement attack. This can lead to premature death of the red blood cells, a process called hemolysis, which results in severe anemia and contributes to a high risk of clotting. AMY-101 tames this inappropriate complement activation and protects cell surfaces from attack.

Although one treatment exists for PNH, one third of patients continue to require blood transfusions to manage their anemia. This non-response is due the accumulation of fragments of complement C3 proteins on the surface of their red blood cells, which are eventually attacked by immune cells. The team investigated the effect of AMY-101 on self-attack and resulting hemolysis using human PNH cells and found it be active.

Editors Note: Lambris is an inventor of patents and/or patent applications owned by Penn that describe the use of complement inhibitors for therapeutic purposes. Lambris is a founder and equity holder of Amyndas Pharmaceuticals, which has exclusively licensed the AMY-101 technologies from Penn and is developing complement inhibitors for clinical applications.

Go here to see the original:

Drug for Rare Blood Disorder Developed at Penn Receives Orphan Drug Status from the FDA